HomeMSB • ASX
add
Mesoblast Ltd
Nakaraang pagsara
$2.07
Sakop ng araw
$2.06 - $2.14
Sakop ng taon
$1.52 - $3.31
Market cap
2.66B AUD
Average na Volume
3.90M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 25.67M | 1,526.81% |
Gastos sa pagpapatakbo | 12.95M | 43.42% |
Net na kita | -20.08M | 16.21% |
Net profit margin | -78.22 | 94.85% |
Kita sa bawat share | — | — |
EBITDA | -12.53M | -32.56% |
Aktuwal na % ng binabayarang buwis | -1.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 129.98M | 241.78% |
Kabuuang asset | 782.31M | 19.74% |
Kabuuang sagutin | 207.62M | 8.11% |
Kabuuang equity | 574.68M | — |
Natitirang share | 1.29B | — |
Presyo para makapag-book | 4.60 | — |
Return on assets | -4.52% | — |
Return on capital | -4.99% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -20.08M | 16.21% |
Cash mula sa mga operasyon | -15.17M | -46.91% |
Cash mula sa pag-invest | -303.50K | -196.81% |
Cash mula sa financing | -564.00K | 73.55% |
Net change in cash | -15.79M | -26.65% |
Malayang cash flow | -5.91M | -484.19% |
Tungkol
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
Itinatag
2004
Website
Mga Empleyado
81
